A Study to Evaluate the Efficacy and Safety of BR1019A and BR1019B Combination Therapy

This trial is testing a new combination treatment (BR1019A and BR1019B) that targets both type 2 diabetes and high blood pressure in patients who have both conditions. The study aims to evaluate the safety and effectiveness of this combined therapy compared to individual treatments. **You may be eligible if...** - You have both type 2 diabetes and essential (primary) high blood pressure - You are willing to stop your current blood pressure and/or diabetes medications (except metformin) during the trial, under medical supervision - Your doctor agrees this temporary change is safe for you **You may NOT be eligible if...** - You have secondary high blood pressure (caused by a specific identifiable condition) - You have symptomatic low blood pressure when standing - You have type 1 diabetes, diabetic coma, severe diabetic complications, or ketoacidosis - You have diabetic kidney disease and are taking ACE inhibitors - You have moderate to severe kidney impairment and are on renin inhibitors - You have uncontrolled severe diabetic complications affecting blood vessels, nerves, or kidneys Talk to your doctor to see if this trial is right for you.